Elysium Therapeutics
UEI: CQ2LJLATAKH9
• CAGE: 6Y1G3
Overview
Awardee Type
Parent
Name
Elysium Therapeutics
Website
Headquarters
Lyons, CO
United States
United States
Most Recent Award
June 15, 2018
Calculating
Federal grant recipient
ELYSIUM THERAPEUTICS, INC.
(UEI CQ2LJLATAKH9, CAGE 6Y1G3)
is headquartered in Lyons CO.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in May 2013 and
federally registered in
July 2013.
Federal Award Analysis
Elysium Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ELYSIUM THERAPEUTICS, INC.
UEI
CQ2LJLATAKH9
CAGE Code
6Y1G3
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 1, 2013
Initial Registration
July 25, 2013
Last Registration
Jan. 9, 2025
Registration Activation
Jan. 1, 2025
Registration Expiration
Dec. 30, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No